RVL PHARMACEUTICALS PLC (RVLP) Earnings History & Surprises
NASDAQ:RVLP • IE00BF2HDL56
0.0282 USD
-0.01 (-32.05%)
At close: Oct 20, 2023
0.0223 USD
-0.01 (-20.92%)
After Hours: 10/20/2023, 8:09:06 PM
Past quarterly earnings results for RVL PHARMACEUTICALS PLC (RVLP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateNov 8, 2023
PeriodQ3 / 2023
EPS Estimate-$0.09
Revenue Estimate6.728M
Last Reported
Release DateAug 14, 2023
PeriodQ2 / 2023
EPS Reported-$0.24
EPS Surprise -108.96%
Revenue Surprise -23.76%
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | -0.24 | -0.11 | -108.96% | -71.43% | 8.258M | 10.831M | -23.76% | -2.25% |
| Q1 2023 | -0.12 | -0.12 | 0.80% | 52.00% | 8.832M | 9.63M | -8.29% | -58.81% |
| Q4 2022 | -0.18 | -0.16 | -10.52% | 40.00% | 9.807M | 12.856M | -23.72% | 242.90% |
| Q3 2022 | -0.16 | -0.16 | 1.47% | 42.86% | 10.022M | 10.421M | -3.83% | 356.38% |
| Q2 2022 | -0.14 | -0.21 | 33.85% | 50.00% | 8.448M | 8.689M | -2.77% | -32.12% |
| Q1 2022 | -0.25 | -0.18 | -42.71% | -66.67% | 21.444M | 7.588M | 182.60% | 2,193.48% |
| Q4 2021 | -0.30 | -0.27 | -10.29% | 65.91% | 2.86M | 3.164M | -9.61% | -91.72% |
| Q3 2021 | -0.28 | -0.32 | 12.85% | -100.00% | 2.196M | 2.405M | -8.69% | -91.47% |
| Q2 2021 | -0.28 | -0.14 | -96.08% | -27.27% | 12.445M | 35.241M | -64.69% | -70.12% |
| Q1 2021 | -0.15 | -0.24 | 37.42% | -200.00% | 935K | 31.263M | -97.01% | -97.98% |
| Q4 2020 | -0.88 | -0.24 | -264.54% | - | 34.532M | 36.448M | -5.26% | - |
| Q3 2020 | -0.14 | -0.20 | 31.37% | - | 25.751M | 37.783M | -31.85% | - |
| Q2 2020 | -0.22 | -0.13 | -72.55% | - | 41.65M | - | - | |
| Q1 2020 | -0.05 | -0.15 | 65.80% | - | 46.381M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-29.30%
Max EPS beat (4)
1.47%
Min EPS beat (4)
-108.97%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-14.90%
Max Revenue beat (4)
-3.83%
Min Revenue beat (4)
-23.76%
Analysis
In the last 4 quarters, RVLP has beaten EPS estimates in 2 out of 4 releases
RVLP has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, RVLP reported -29.3% below the EPS estimates on average.
In the last 4 quarters, RVLP reported -14.9% below the revenue estimates on average.
RVL PHARMACEUTICALS PLC / RVLP Earnings FAQ
What is the most recent earnings date for RVLP stock?
RVL PHARMACEUTICALS PLC (RVLP) last reported earnings on 8/14/2023.
Can you provide information on whether RVL PHARMACEUTICALS PLC beat earnings estimates in the last quarter?
RVL PHARMACEUTICALS PLC (RVLP) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does RVLP stock beat earnings estimates?
In the last 4 quarters, RVL PHARMACEUTICALS PLC (RVLP) has beaten EPS estimates in 2 out of 4 releases.